Understanding acute myeloid leukemia

Acute myeloid leukemia (AML) is a rare disease that primarily affects the elderly. It is a cancer of the blood and bone marrow that can progress rapidly when left untreated. Acute myeloid leukemia is the most common acute leukemia in adults and affects 5 out of 100,000 people in Europe 1. The five-year survival rate of patients with AML over the age of 60 is less than 10% 2, underscoring the ...

Understanding acute myeloid leukemia Acute myeloid leukemia (AML) is a rare disease that primarily affects the elderly. It is a cancer of the blood and bone marrow that can progress rapidly when left untreated. Acute myeloid leukemia is the most common acute leukemia in adults and affects five out of 100,000 people living in Europe 1.
Downloadable Resources for Patients
:max_bytes(150000):strip_icc()/Health-GI-background-light-purple-v2-b6deafbace3b4a4bb866d69b6a38d7fb.jpg)
Acute Myeloid Leukemia (AML) Explore MyAMLJourney for a range of resources tailored to Acute Myeloid Leukemia (AML). Find valuable information on understanding and managing your condition, ensuring you are well-informed and supported at every step of your journey. Prepare for your next doctor's appointment >
Understanding Acute Myeloid Leukemia (AML) A guide for diagnosing, testing, and treating patients with AML Format: PDF (13 pages) Presented by Servier Posted: 4/2026
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is the most common acute leukemia affecting adults. The disease occurs when a mutation takes place in the DNA of a type of white blood cell called a myeloblast that is found in bone marrow.
An Acute Myeloid Leukemia (AML) diagnosis is difficult news for you and your loved ones. Servier Pharmaceuticals has created this site to help you understand your condition and the testing and treatment options that may be available for you.

PDF What is Acute Myeloid Leukemia (AML)
What is Acute Myeloid Leukemia (AML)? AML is one of the most common types of leukemia in adults, and its incidence significantly increases with age. About 20,050 people will be diagnosed with AML this year.1 The median age of diagnosis is 68 years old.1,2 It occurs when a mutation takes place in the DNA of a type of white blood cell called a myeloblast that is found in bone marrow.
Understanding Acute Myeloid Leukemia (AML)1 ʻ ̆˔˟˧ ̨ˬ ˕sl ̆ ɣ˔˥˥s˪ x˥s˗˨˖ ̆˦ ˥ ̆˗ ˕˟ss˗ ˖ ̆˟˟˦ʟ ˪ ̨ ̃˧ ̆ ˕˟ss˗ ˖ ̆˟˟˦ʟ ˔l˗ x˟˔˧ ̆˟ ̆˧˦ʡ ˇ ̨ ̆˦ ̆ ˖ ̆˟˟˦ ˔˥ ̆ ̆˦˦ ̆l˧ ̃˔˟ ̃l ˧˥˔l˦xs˥˧ ̃l ̊ s˫ˬ ̊ ̆lʟ ̨ ̆˟x ̃l ̊ Ѓ ̊ ̨˧ ̃l ̇ ̆˖˧ ̃sl˦ʟ ˔l˗ ˔˦˦ ̃˦˧ ̃l ̊ ̃l ˕˟ss˗ ˖˟s˧˧ ̃l ̊ʡ

Acute Myeloid Leukemia
A Collaborative Exchange on Evolving Strategies in IDH1-Mutated Myeloid Malignancies WATCH DR. TAPAN M. KADIA, DR. GAIL J. ROBOZ, DR. TOM LEBLANC, AND DR. HETTY CARRAWAY DISCUSS EVOLVING TREATMENT STRATEGIES AND REAL-WORLD CONSIDERATIONS FOR MANAGING PATIENTS WITH IDH1-MUTATED MYELOID MALIGNANCIES.




Treatment options for adult acute myeloid leukemia (AML) include chemotherapy, radiation therapy, stem cell transplant, and other medications. Get detailed information about the treatment of new and recurrent AML in this expert-reviewed summary.